|
FENC | Fennec Pharmaceuticals Inc. |
|
|
FENC | Fennec Pharmaceuticals Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ -0.02 |
| Leverage | 109.12% |
| Market Cap | $ 208.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -7.0m |
| Margin | -18.98% |
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops candidate products for use in the treatment of cancer in the United States. The company is headquartered in Research Triangle Park, North Carolina.